We are live on ! Find out more
MDSL

M.D. Sass LLC Portfolio holdings

AUM $1.32B
1-Year Est. Return 16.01%
This Fund
S&P 500
This Quarter Est. Return
-6.33%
1 Year Est. Return
+16.01%
3 Year Est. Return
+54.62%
5 Year Est. Return
+70.79%
10 Year Est. Return
+248.43%
AUM
$859M
AUM Growth
-$259M
Cap. Flow
-$201M
Cap. Flow %
-23.38%
Top 10 Hldgs %
43.11%
Holding
56
New
9
Increased
18
Reduced
14
Closed
14

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 21.45%
2 Communication Services 13.41%
3 Healthcare 10.92%
4 Technology 10.87%
5 Financials 10.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LSXMK
51
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
-138,209
Closed -$4.17M
CVA
52
DELISTED
Covanta Holding Corporation
CVA
-1,112,715
Closed -$18.8M
AGN
53
DELISTED
Allergan plc
AGN
-37,500
Closed -$6.13M
LVNTA
54
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
-544,665
Closed -$29.5M
GNCMA
55
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
-192,000
Closed -$7.49M
CELG
56
DELISTED
Celgene Corp
CELG
-301,389
Closed -$31.5M

Similar funds

M.D. Sass LLC's Q1 2018 Portfolio in Review

As of Q1 2018, M.D. Sass LLC held 56 positions worth $859M, down 23% from $1.12B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

M.D. Sass LLC withdrew a net $201M in Q1 2018, closing 14 positions and reducing 14 holdings. Its most notable exit was Celgene Corp, an estimated $31.5M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 15% a quarter earlier, followed by Communication Services and Healthcare.

Against the trend, M.D. Sass LLC opened a new position in Caesars Entertainment Corporation worth $36.3M.

  • M.D. Sass LLC's largest Q1 2018 buy was Caesars Entertainment Corporation: 3,229,275 shares worth $36.3M.
  • M.D. Sass LLC added most to NRG Energy in Q1 2018, an estimated $35.7M increase.
  • M.D. Sass LLC's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $228M.
  • M.D. Sass LLC fully exited Celgene Corp in Q1 2018, selling an estimated $31.5M.
  • M.D. Sass LLC's ten largest holdings make up 43% of its $859M portfolio in Q1 2018.
  • M.D. Sass LLC opened 9 new positions and closed 14 in Q1 2018.
  • M.D. Sass LLC's portfolio value fell 23% quarter-over-quarter to $859M.

Based on M.D. Sass LLC's 13F filing for Q1 2018, filed 14 May 2018.